US 8834938
Use of arsenic for cancer therapy protection
granted A61KA61K33/36A61K41/00
Quick answer
US patent 8834938 (Use of arsenic for cancer therapy protection) held by The Board of Regents of the University of Texas System expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K33/36, A61K41/00, A61P, A61P35/00